Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Imexon - AmpliMed

Next Previous
X
Search
Drug Profile

Imexon - AmpliMed

Alternative Names: Amplimexon; BM 06002

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AmpliMed
  • Class Antineoplastics; Antivirals; Hexanones; Small molecules
  • Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Reactive oxygen species stimulants; Ribonucleotide reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Malignant melanoma; Multiple myeloma; Ovarian cancer; Pancreatic cancer
  • New Molecular Entity No

Highest Development Phases

  • No development reported Breast cancer; Lung cancer; Malignant melanoma; Multiple myeloma; Non-Hodgkin's lymphoma; Ovarian cancer; Prostate cancer
  • Discontinued Pancreatic cancer

Most Recent Events

  • 04 Aug 2015 No recent reports on development identified - Phase-I for Breast cancer, Lung cancer and Prostate cancer in USA (IV)
  • 04 Aug 2015 No recent reports on development identified - Phase-I/II for Malignant melanoma, Multiple myeloma, and Non-Hodgkin's lymphoma (Second-line therapy or greater) in USA (IV)
  • 01 Jul 2013 Handok Pharmaceuticals is now called Handok Inc

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top